SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Knutson Gregory

(Last) (First) (Middle)
1560 SAWGRASS CORPORATE PARKWAY
4TH FLOOR

(Street)
SUNRISE FL 33323

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
U.S. Stem Cell, Inc. [ USRM ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
04/01/2020
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 1,675,000 D
Common Stock 04/01/2020 04/01/2020 J(1) 1,445,647 A(1) $0.006 32,251,149 I Held by NorthStar Biotech Group, LLC of which Gregory Knutson is Managing Director
Common Stock 10/05/2020 10/05/2020 J(1) 2,035,820 A(1) $0.0045 35,286,969 I Held by NorthStar Biotech Group, LLC of which Gregory Knutson is Managing Director
Common Stock 04/02/2021 04/02/2021 J(1) 187,575 A(1) $0.0487 35,474,544 I Held by NorthStar Biotech Group, LLC of which Gregory Knutson is Managing Director
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Convertible promissory Note (right to buy) $0.0266 02/17/2021 02/17/2021 A 3,759,398 02/17/2021 02/17/2022 Common Stock 3,759,398 $100,000 7,384,398 D
Explanation of Responses:
1. Interest payment on outstanding debt.
/s/ Gregory Knutson 07/23/2021
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
US Stem Cell (PK) (USOTC:USRM)
Historical Stock Chart
From Dec 2021 to Jan 2022 Click Here for more US Stem Cell (PK) Charts.
US Stem Cell (PK) (USOTC:USRM)
Historical Stock Chart
From Jan 2021 to Jan 2022 Click Here for more US Stem Cell (PK) Charts.